USD10
GHRS Shares
About GH ResearchGH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

USD10
GHRS Shares
About GH ResearchGH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

Stats

TRADING WINDOW

Closed

OPENS AT

Not enough data

MARKET CAP

$1.25B

OPEN PRICE

$18.92

LOW (1Y)

$12.04

HIGH (1Y)

$31.44

LOW (24H)

$18.05

HIGH (24H)

$19.32

VOLUME (24H)

$162.61K

41.24%

Price history

Time
Price
Change
Today
$18.92
4.07%
1 Day
$18.92
4.07%
1 Week
$21.13
14.10%
1 Month
$28.13
35.48%
1 Year
$14.00
29.64%
Past performance is not a reliable indicator of future results.

Discover more

Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.